Panbela Therapeutics Faces Sharp Stock Decline Amid Public Offering Announcement
TL;DR Summary
Panbela Therapeutics shares plummeted by 65.5% after announcing a $9 million public offering, while other stocks experienced significant movement during Monday's mid-day session, with Palisade Bio, Inc. and OneMedNet Corporation among the gainers, and SMX (Security Matters) Public Limited Company and Inspire Veterinary Partners, Inc. among the losers.
Topics:business#finance#mid-day-session#panbela-therapeutics#public-offering#stock-market#stock-movement
- Why Panbela Therapeutics Shares Are Trading Lower By 65%? Here Are Other Stocks Moving In Monday's Mid-Day Session - Arrival (NASDAQ:ARVL), Aclarion (NASDAQ:ACON) Benzinga
- Why Is Panbela Therapeutics (PBLA) Stock Down 63% Today? InvestorPlace
- Panbela Therapeutics Shares Slide Premarket After Public Offering MarketWatch
- Panbela Announces Pricing of Approximately $9.0 Million Public Offering GlobeNewswire
- Panbela Therapeutics Inc (PBLA) Up 18.15% in Premarket Trading InvestorsObserver
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
3 min
vs 4 min read
Condensed
93%
693 → 48 words
Want the full story? Read the original article
Read on Benzinga